论文部分内容阅读
目的:讨论升白汤治疗恶性肿瘤化疗后白细胞减少症的临床疗效。方法:以我院在2015年1月-2016年9月收治的30例恶性肿瘤化疗后白细胞减少症患者作为研究对象,使用升白汤对其进行治疗(观察组),与我院前期收治的30例使用鲨肝醇和利血生治疗的患者作为对照组。比较两组的治疗总有效率。结果 :观察组患者的治疗总有效率明显优于对照组,两组之间存在显著差异,p<0.05,有统计学意义。结论 :使用升白汤治疗恶性肿瘤化疗后白细胞减少的患者,有很好的治疗效果,值得在临床上推广使用。
Objective: To discuss the clinical efficacy of Shengbai decoction in the treatment of leucopenia after chemotherapy. Methods: Thirty patients with leucopenia who underwent chemotherapy in our hospital from January 2015 to September 2016 were enrolled in this study. The patients were treated with Shengbai Decoction (observation group) and 30 Patients treated with shark liver alcohol and leiomyelitis served as controls. The total effective rate was compared between the two groups. Results: The total effective rate of observation group was significantly better than that of control group, there was significant difference between the two groups, p <0.05, with statistical significance. Conclusion: The use of Shengbai decoction in the treatment of patients with leukopenia after chemotherapy, has a good therapeutic effect, it is worth in the clinical promotion.